18. Nougayrède JP, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 2006; 313:848-51; PMID:16902142; http:// dx.doi.org/10.1126/science.1127059. 19. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrède JP. Escherichia coli induces DNA damage in vivo and triggers genomic instabil- ity in mammalian cells. Proc Natl Acad Sci U S A 2010; 107:11537-42; PMID:20534522; http://dx.doi. org/10.1073/pnas.1001261107. 20. Grabig A, Paclik D, Guzy C, Dankof A, Baumgart DC, Erckenbrecht J, et al. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Infect Immun 2006; 74:4075-82; PMID:16790781; http:// dx.doi.org/10.1128/IAI.01449-05. 21. Kamada N, Inoue N, Hisamatsu T, Okamoto S, Matsuoka K, Sato T, et al. Nonpathogenic Escherichia coli strain Nissle1917 prevents murine acute and chronic colitis. Inflamm Bowel Dis 2005; 11:455- 63; PMID:15867585; http://dx.doi.org/10.1097/01. MIB.0000158158.55955.de. 22. Schultz M, Strauch UG, Linde HJ, Watzl S, Obermeier F, Göttl C, et al. Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis. Clin Diagn Lab Immunol 2004; 11:372-8; PMID:15013990. 23. Ukena SN, Singh A, Dringenberg U, Engelhardt R, Seidler U, Hansen W, et al. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One 2007; 2:e1308; PMID:18074031; http://dx.doi.org/10.1371/journal.pone.0001308. 24. Velayos FS, Terdiman JP, Walsh JM. Effect of 5-ami- nosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observa- tional studies. Am J Gastroenterol 2005; 100:1345-53; PMID:15929768; http://dx.doi.org/10.1111/j.1572- 0241.2005.41442.x. 25. Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 2010; 10:735-44; PMID:20865020; http:// dx.doi.org/10.1038/nri2850. 26. Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol 2010; 8:564-77; PMID:20622892; http://dx.doi. org/10.1038/nrmicro2403. 27. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134:577-94; PMID:18242222; http://dx.doi.org/10.1053/j.gas- tro.2007.11.059. 28. Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, Delaney ML, et al. Enterobacteriaceae act in concert with the gut microbiota to induce sponta- neous and maternally transmitted colitis. Cell Host Microbe 2010; 8:292-300; PMID:20833380; http:// dx.doi.org/10.1016/j.chom.2010.08.004. 29. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007; 2:204; PMID:18030708; http:// dx.doi.org/10.1016/j.chom.2007.08.002. 30. Lee IA, Bae EA, Hyun YJ, Kim DH. Dextran sul- fate sodium and 2,4,6-trinitrobenzene sulfonic acid induce lipid peroxidation by the proliferation of intestinal gram-negative bacteria in mice. J Inflamm (Lond) 2010; 7:7; PMID:20181058; http://dx.doi. org/10.1186/1476-9255-7-7. 31. Carvalho FA, Barnich N, Sauvanet P, Darcha C, Gelot A, Darfeuille-Michaud A. Crohn’s disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin. Inflamm Bowel Dis 2008; 14:1051-60; PMID:18338780; http:// dx.doi.org/10.1002/ibd.20423. 32. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn’s disease. Gastroenterology 1998; 115:1405-13; PMID:9834268; http://dx.doi. org/10.1016/S0016-5085(98)70019-8. 33. Kim SC, Tonkonogy SL, Karrasch T, Jobin C, Sartor RB. Dual-association of gnotobiotic IL-10-/- mice with 2 nonpathogenic commensal bacteria induces aggres- sive pancolitis. Inflamm Bowel Dis 2007; 13:1457- 66; PMID:17763473; http://dx.doi.org/10.1002/ ibd.20246. 34. Waidmann M, Bechtold O, Frick JS, Lehr HA, Schubert S, Dobrindt U, et al. Bacteroides vulgatus protects against Escherichia coli-induced colitis in gno- tobiotic interleukin-2-deficient mice. Gastroenterology 2003; 125:162-77; PMID:12851881; http://dx.doi. org/10.1016/S0016-5085(03)00672-3. 35. Azaïs-Braesco V, Bresson JL, Guarner F, Corthier G. Not all lactic acid bacteria are probiotics, ...but some are. Br J Nutr 2010; 103:1079-81; PMID:20230653; http://dx.doi.org/10.1017/S0007114510000723. 36. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 2000; 97:6640-5; PMID:10829079; http://dx.doi. org/10.1073/pnas.120163297. 37. Houdeau E, Moriez R, Leveque M, Salvador-Cartier C, Waget A, Leng L, et al. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat. Gastroenterology 2007; 132:982-93; PMID:17324399; http://dx.doi. org/10.1053/j.gastro.2006.12.028. 38. Morrissey PJ, Charrier K, Braddy S, Liggitt D, Watson JD. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease devel- opment is prevented by cotransfer of purified CD4+ T cells. J Exp Med 1993; 178:237-44; PMID:8100269; http://dx.doi.org/10.1084/jem.178.1.237. 39. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 1993; 5:1461- 71; PMID:7903159; http://dx.doi.org/10.1093/ intimm/5.11.1461. 40. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273:5858-68; PMID:9488723; http://dx.doi. org/10.1074/jbc.273.10.5858. www.landesbioscience.com Gut Microbes 509